Medically reviewed by Oliinyk Elizabeth Ivanovna, PharmD. Last updated on 2020-04-08
Attention! Information on this page is intended only for medical professionals! Information is collected in open sources and may contain significant errors! Be careful and double-check all the information on this page!
Inside, regardless of the meal, without chewing, with a sufficient amount of liquid, once a day. The duration of the course of treatment is determined by the doctor individually in each specific case and depends on the nature of the disease and the effectiveness of therapy.
Adults and children with a body weight of more than 20 kg. The initial dose is 1 mcg/day. The maintenance dose is 0.25-2 mcg/day.
With rickets and osteomalacia — from 1 to 3 mcg/day, with hypoparathyroidism-1-4 mcg/day, with osteodystrophy with CRF-0.5-2 mcg/day, with osteoporosis (including postmenopausal, senile, steroid) - 0.5-1 mcg/day.
It is recommended to start treatment with minimal doses, monitoring the concentration of calcium and phosphorus in the blood plasma once a week. The dose of the drug can be increased by 0.25 or 0.5 mcg/day until the biochemical parameters are stabilized. When the minimum effective dose is reached, it is recommended to monitor the concentration of calcium in the blood plasma every 3-5 weeks.
- Vitamin-calcium-phosphorus metabolism regulator [Correctors of bone and cartilage metabolism]
- Vitamin-calcium-phosphorus metabolism regulator [Vitamins and vitamin-like products]
At a temperature not exceeding 25 °C.
Keep out of reach of children.Shelf life of the drug Alpha D3-Teva®3 года.
Do not use after the expiration date indicated on the package.
|Capsules of 0.25/1 µg||1 caps.|
|alfacalcidol||Of 0.25/1 µg|
|excipients: citric acid-0.015/0.015 mg, propyl gallate-0.02/0.02 mg, α-tocopherol-0.02/0.02 mg, ethanol-1.145/1.144 mg, peanut butter-98.79975/98.8 mg|
|shell (soft gelatin capsule):|
|* Butanol, water, denatured ethanol (methylated alcohol), isopropanol, water ammonia — volatile compounds that completely evaporate during the application of labels on capsules and do not remain on the surface of the capsules|
The capsule is 0.25 mcg, 1 mcg. 10 caps each in a blister made of light-proof PVC and aluminum foil.
Dosage 1 mcg: 10 or 30 caps each in a high-pressure polypropylene bottle with a polypropylene cap.
Dosage of 0.25 mcg: 30 or 60 caps each in a high-pressure polypropylene bottle with a polypropylene cap.
Each bottle, 1 or 3 bl. is placed in a cardboard pack.
According to the recipe.
- E20 Hypoparathyroidism
- E20. 1 Pseudohypoparathyroidism
- E83. 3 Phosphorus metabolism disorders
- E83. 3. 2 * Rickets vitamin D-resistant
- E83. 5 Calcium metabolism disorders
- M81. 0 Postmenopausal osteoporosis
- M81. 4 Medicinal osteoporosis
- M81. 8. 0 * Senile osteoporosis
- M81. 9 Osteoporosis, unspecified
- M83 Osteomalacia in adults
- N25. 0 Renal osteodystrophy
However, we will provide data for each active ingredient